Influence of Body Weight Category on Outcomes in Candidemia Patients Treated With Anidulafungin.

There was no difference detected in mortality among patients with candidemia across BMI category. Larger studies are needed to confirm whether standard doses of anidulafungin are sufficient for candidemia in obese patients.